MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

Search

Pacific Biosciences of California Inc

Cerrado

SectorSanidad

1.44 -1.37

Resumen

Variación precio

24h

Actual

Mínimo

1.43

Máximo

1.52

Métricas clave

By Trading Economics

Ingresos

-428M

-426M

Ventas

-2.1M

37M

Margen de beneficios

-1,146.812

Empleados

575

EBITDA

-420M

-403M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+49.32% upside

Dividendos

By Dow Jones

Próximas Ganancias

6 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

141M

480M

Apertura anterior

2.81

Cierre anterior

1.44

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

154 / 376 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Pacific Biosciences of California Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

15 jul 2025, 23:41 UTC

Charlas de Mercado

Nikkei May Trade in Range Amid Tariff Uncertainty -- Market Talk

15 jul 2025, 23:40 UTC

Charlas de Mercado

Gold Edges Higher on Possible Position Adjustments -- Market Talk

15 jul 2025, 23:05 UTC

Charlas de Mercado

Auckland International Airport Passenger Growth May Disappoint Again -- Market Talk

15 jul 2025, 21:36 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

15 jul 2025, 21:36 UTC

Charlas de Mercado

Canada CPI Data Fuel Rate-Prediction Revisions -- Market Talk

15 jul 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

15 jul 2025, 20:50 UTC

Charlas de Mercado
Ganancias

Financial Services Roundup: Market Talk

15 jul 2025, 20:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

15 jul 2025, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

15 jul 2025, 20:14 UTC

Adquisiciones, fusiones, absorciones

Chinese EV Makers to Combine. Geely Is Buying Zeekr. -- Barrons.com

15 jul 2025, 20:07 UTC

Ganancias

BlackRock Shares Tumble After Big Client Redemption Blunts Quarterly Results -- Update

15 jul 2025, 20:06 UTC

Charlas de Mercado

Nvidia, AMD Seen Benefiting from Return to Chinese Chip Sales -- Market Talk

15 jul 2025, 19:54 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

15 jul 2025, 19:54 UTC

Charlas de Mercado

Meta CEO Hints at Higher Revenues, Expenses With Data Center Plans -- Market Talk

15 jul 2025, 19:38 UTC

Charlas de Mercado

Oil Falls As Eventual Oversupply Concerns Weigh -- Market Talk

15 jul 2025, 19:09 UTC

Charlas de Mercado

U.S. Natural Gas Futures Post Back-to-Back Gains -- Market Talk

15 jul 2025, 19:07 UTC

Charlas de Mercado

Canada CFOs Willing to Take Risks, Increase Spending -- Market Talk

15 jul 2025, 19:03 UTC

Charlas de Mercado

Gold Slips as Big Buyers Pull Back -- Market Talk

15 jul 2025, 18:32 UTC

Adquisiciones, fusiones, absorciones

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15 jul 2025, 18:31 UTC

Adquisiciones, fusiones, absorciones

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

15 jul 2025, 18:13 UTC

Charlas de Mercado

Canada Adopts 'Note of Realism' in US Trade Talks, Setting Stage for Possible Tariff Deal -- Market Talk

15 jul 2025, 17:40 UTC

Charlas de Mercado

Canadian Inflation Adds to Case for Bank of Canada Extending Pause -- Market Talk

15 jul 2025, 17:40 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

15 jul 2025, 17:25 UTC

Adquisiciones, fusiones, absorciones

National Fuel Gas Gets Rare Double Upgrade. Buy the Stock, Analyst Says. -- Barrons.com

15 jul 2025, 17:24 UTC

Charlas de Mercado

Dollar Gains Strength After Inflation Data -- Market Talk

15 jul 2025, 16:49 UTC

Charlas de Mercado

Oil Futures Likely to Continue Sideways Trade -- Market Talk

15 jul 2025, 16:20 UTC

Charlas de Mercado
Ganancias

Financial Services Roundup: Market Talk

15 jul 2025, 16:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

15 jul 2025, 16:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

15 jul 2025, 15:42 UTC

Charlas de Mercado

Coca-Cola Seen as Top Pick Ahead of Consumer Staples Earnings -- Market Talk

Comparación entre iguales

Cambio de precio

Pacific Biosciences of California Inc previsión

Precio Objetivo

By TipRanks

49.32% repunte

Estimación a 12 Meses

Media 2.18 USD  49.32%

Máximo 3 USD

Mínimo 1.25 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pacific Biosciences of California Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

4

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

1.13 / N/ASoporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

154 / 376 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.